201 related articles for article (PubMed ID: 23088614)
1. BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.
Boeuf S; Bovée JV; Lehner B; van den Akker B; van Ruler M; Cleton-Jansen AM; Richter W
BMC Cancer; 2012 Oct; 12():488. PubMed ID: 23088614
[TBL] [Abstract][Full Text] [Related]
2. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
3. Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.
Morris E; Chrobak I; Bujor A; Hant F; Mummery C; Ten Dijke P; Trojanowska M
J Cell Physiol; 2011 Dec; 226(12):3340-8. PubMed ID: 21344387
[TBL] [Abstract][Full Text] [Related]
4. TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.
Shinohara N; Maeda S; Yahiro Y; Sakuma D; Matsuyama K; Imamura K; Kawamura I; Setoguchi T; Ishidou Y; Nagano S; Komiya S
Sci Rep; 2017 Oct; 7(1):13494. PubMed ID: 29044189
[TBL] [Abstract][Full Text] [Related]
5. Toxicarioside A, isolated from tropical Antiaris toxicaria, blocks endoglin/TGF-β signaling in a bone marrow stromal cell line.
Li YN; Huang FY; Mei WL; Dai HF; Guo JL; Tan GH; Zhou P
Asian Pac J Trop Med; 2012 Feb; 5(2):91-7. PubMed ID: 22221748
[TBL] [Abstract][Full Text] [Related]
6. Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors.
Breen MJ; Moran DM; Liu W; Huang X; Vary CP; Bergan RC
PLoS One; 2013; 8(8):e72407. PubMed ID: 23967299
[TBL] [Abstract][Full Text] [Related]
7. PEG10 counteracts signaling pathways of TGF-β and BMP to regulate growth, motility and invasion of SW1353 chondrosarcoma cells.
Yahiro Y; Maeda S; Shinohara N; Jokoji G; Sakuma D; Setoguchi T; Ishidou Y; Nagano S; Komiya S; Taniguchi N
J Bone Miner Metab; 2019 May; 37(3):441-454. PubMed ID: 30094509
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
9. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
[TBL] [Abstract][Full Text] [Related]
10. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells.
O'Connor JC; Farach-Carson MC; Schneider CJ; Carson DD
Mol Cancer Res; 2007 Jun; 5(6):585-603. PubMed ID: 17579118
[TBL] [Abstract][Full Text] [Related]
11. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.
Lee NY; Ray B; How T; Blobe GC
J Biol Chem; 2008 Nov; 283(47):32527-33. PubMed ID: 18775991
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix-mediated signaling by dentin phosphophoryn involves activation of the Smad pathway independent of bone morphogenetic protein.
Jadlowiec JA; Zhang X; Li J; Campbell PG; Sfeir C
J Biol Chem; 2006 Mar; 281(9):5341-7. PubMed ID: 16326713
[TBL] [Abstract][Full Text] [Related]
13. Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation.
Ishibashi O; Ikegame M; Takizawa F; Yoshizawa T; Moksed MA; Iizawa F; Mera H; Matsuda A; Kawashima H
J Cell Physiol; 2010 Feb; 222(2):465-73. PubMed ID: 19918795
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells.
Tang Y; Yang X; Friesel RE; Vary CP; Liaw L
J Vasc Res; 2011; 48(6):485-94. PubMed ID: 21832838
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261
[TBL] [Abstract][Full Text] [Related]
16. Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes.
Finnson KW; Parker WL; Chi Y; Hoemann CD; Goldring MB; Antoniou J; Philip A
Osteoarthritis Cartilage; 2010 Nov; 18(11):1518-27. PubMed ID: 20833252
[TBL] [Abstract][Full Text] [Related]
17. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
[TBL] [Abstract][Full Text] [Related]
18. ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.
Ray BN; Lee NY; How T; Blobe GC
Carcinogenesis; 2010 Mar; 31(3):435-41. PubMed ID: 20042635
[TBL] [Abstract][Full Text] [Related]
19. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro.
Tian F; Zhou AX; Smits AM; Larsson E; Goumans MJ; Heldin CH; Borén J; Akyürek LM
Biochem Biophys Res Commun; 2010 Feb; 392(3):283-8. PubMed ID: 20060813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]